World Library  
Flag as Inappropriate
Email this Article

Alopecia areata


Alopecia areata

Alopecia areata
Alopecia areata.
Classification and external resources
Specialty Dermatology
ICD-10 L63
ICD-9-CM 704.01
OMIM 104000
DiseasesDB 430
MedlinePlus 001450
eMedicine derm/14
MeSH D000506

Alopecia areata (AA), also known as spot baldness, is an autoimmune disease in which hair is lost from some or all areas of the body, usually from the scalp due to the body's failure to recognize its own body cells and destroys its own tissue as if it were an invader.[1][2] Often it causes bald spots on the scalp, especially in the first stages. In 1–2% of cases, the condition can spread to the entire scalp (alopecia totalis) or to the entire epidermis (alopecia universalis). Conditions resembling AA, and having a similar cause, occur also in other species.[3]


  • Classification 1
  • Signs and symptoms 2
  • Diagnosis 3
  • Causes 4
  • Treatment 5
  • Prognosis 6
  • Epidemiology 7
  • Research 8
  • See also 9
  • References 10
  • External links 11


Commonly, alopecia areata involves hair loss in one or more round spots on the scalp.[2][4]

  • Hair may also be lost more diffusely over the whole scalp, in which case the condition is called diffuse alopecia areata.[2]
  • Alopecia areata monolocularis describes baldness in only one spot. It may occur anywhere on the head.
  • Alopecia areata multilocularis refers to multiple areas of hair loss.
  • Ophiasis refers to hair loss in the shape of a wave at the circumference of the head.
  • The disease may be limited only to the beard, in which case it is called alopecia areata barbae.[2]
  • If the patient loses all the hair on the scalp, the disease is then called alopecia totalis.
  • If all body hair, including pubic hair, is lost, the diagnosis then becomes alopecia universalis.[5]

Alopecia areata totalis and universalis are rare.[5]

Signs and symptoms

Alopecia areata

Typical first symptoms of AA are small bald patches. The underlying skin is unscarred and looks superficially normal. These patches can take many shapes, but are most usually round or oval.[6] AA most often affects the scalp and beard, but may occur on any hair-bearing part of the body.[7] Different skin areas can exhibit hair loss and regrowth at the same time. The disease may also go into remission for a time, or may be permanent. It is common in children.

The area of hair loss may tingle or be painful.[8]

The hair tends to fall out over a short period of time, with the loss commonly occurring more on one side of the scalp than the other.[2]

Exclamation point hairs, narrower along the length of the strand closer to the base, producing a characteristic "exclamation point" appearance, are often present.[2]

When healthy hair is pulled out, at most a few should come out, and ripped hair should not be distributed evenly across the tugged portion of the scalp. In cases of AA, hair will tend to pull out more easily along the edge of the patch where the follicles are already being attacked by the body's immune system than away from the patch where they are still healthy.[9]

Nails may have pitting or trachyonychia.[7]


Alopecia areata is usually diagnosed based on clinical features.

Trichoscopy may aid differential diagnosis. In AA, trichoscopy shows regularly distributed "yellow dots" (hyperkeratotic plugs), small exclamation-mark hairs, and "black dots" (destroyed hairs in the hair follicle opening).[10]

A biopsy is rarely needed in AA. Histologic findings include peribulbar lymphocytic infiltrate ("swarm of bees"). Occasionally, in inactive AA, no inflammatory infiltrates are found. Other helpful findings include pigment incontinence in the hair bulb and follicular stelae, and a shift in the anagen-to-telogen ratio towards telogen.


Alopecia areata is not contagious.[2] It occurs more frequently in people who have affected family members, suggesting heredity may be a factor.[2] Strong evidence of genetic association with increased risk for AA was found by studying families with two or more affected members. This study identified at least four regions in the genome that are likely to contain these genes.[11] In addition, it is slightly more likely to occur in people who have relatives with autoimmune diseases.

The condition is thought to be a systemic autoimmune disorder in which the body attacks its own anagen hair follicles and suppresses or stops hair growth.[2] For example, T cell lymphocytes cluster around affected follicles, causing inflammation and subsequent hair loss. A few cases of babies being born with congenital AA have been reported, but these are not cases of autoimmune disease, because an infant is born without a definitely developed immune system.

Endogenous retinoids metabolic defect is a key part of the pathogenesis of the AA.[12]

In 2010, a genome-wide association study was completed that identified 129 SNPs (single nucleotide polymorphisms) that were associated with alopecia areata. The genes that were identified include regulatory T cells, cytotoxic T lymphocyte-associated antigen 4, interleukin-2, interleukin-2 receptor A, Eos, cytomegalovirus UL16-binding protein, and the human leukocyte antigen region. The study also identified two genes, PRDX5 and STX17, that are expressed in the hair follicle.[13]

Also, some evidence indicates AA affects the part of the hair follicle associated with hair color. Hair that has turned gray may not be affected.


If the affected region is small, it is reasonable to only observe the progression of the illness, as the problem often spontaneously regresses and the hair may grow back.

In cases of severe hair loss, limited success has been shown from treating AA with the corticosteroids clobetasol or fluocinonide, corticosteroid injections, or cream. The cream however is not as effective and it takes longer in order to see results. Steroid injections are commonly used in sites where the areas of hair loss on the head are small or especially where eyebrow hair has been lost. Whether they are effective is uncertain. Some other medications used are minoxidil, Elocon (mometasone) ointment (steroid cream), irritants (anthralin or topical coal tar), and topical immunotherapy cyclosporin, sometimes in different combinations. Topical corticosteroids frequently fail to enter the skin deeply enough to affect the hair bulbs, which are the treatment target,[7] and small lesions typically also regrow spontaneously. Oral corticosteroids decrease the hair loss, but only for the period during which they are taken, and these drugs have serious adverse side effects.[7]


In most cases which begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to AA totalis or, in rare cases, AA universalis.[8]

Effects of AA are mainly psychological (loss of self-image due to hair loss). Loss of hair also means the scalp burns more easily in the sun. Patients may also have aberrant nail formation because keratin forms both hair and nails.

Hair may grow back and then fall out again later. This may not indicate a recurrence of the condition, however, but rather a natural cycle of growth-and-shedding from a relatively synchronised start; such a pattern will fade over time. Episodes of AA before puberty predispose one to chronic recurrence of the condition.[7]

Alopecia can certainly be the cause of psychological stress. Because hair loss can lead to significant appearance changes, individuals may experience social phobia, anxiety, and depression.


The condition affects 0.1%–0.2% of humans,[14] occurring in both males and females. Alopecia areata occurs in people who are apparently healthy and have no skin disorder.[7] Initial presentation most commonly occurs in the late teenage years, early childhood, or young adulthood, but can happen with people of all ages.[2] Patients also tend to have a slightly higher incidence of conditions related to the immune system: asthma, allergies, atopic dermal ailments, and hypothyroidism.


A number of medications are under trial

  • Abatacept (Orencia), which is FDA-approved for the treatment of rheumatoid arthritis
  • Triamcinolone acetonide, which although already used for the treatment of alopecia areata, has never been rigorously tested. They will also test the immunological changes associated with the drug.[15]

See also


  1. ^ Odom, Richard B.; Davidsohn, Israel; James, William D.; Henry, John Bernard; Berger, Timothy G.; Clinical diagnosis by laboratory methods; Dirk M. Elston (2006). Andrews' diseases of the skin: clinical dermatology. Saunders Elsevier.  
  2. ^ a b c d e f g h i j Zoe Diana Draelos (August 30, 2007), Alopecia Areata. Retrieved on December 2, 2007
  3. ^ McElwee, Kevin J.; Boggess, Dawnalyn; Olivry, Thierry; Oliver, Roy F.; Whiting, David; Tobin, Desmond J.; Bystryn, Jean-Claude; King, Jr., Lloyd E.; Sundberg, John P. (1998). "Comparison of Alopecia areata in Human and Nonhuman Mammalian Species". Pathobiology 66 (2): 90–107.  
  4. ^ Marks, James G; Miller, Jeffery (2006). Lookingbill and Marks' Principles of Dermatology (4th ed.). Elsevier Inc. ISBN 1-4160-3185-5.
  5. ^ a b Skin Conditions: Alopecia Areata. WebMD. Retrieved on December 2, 2007.
  6. ^ Freedberg, Irwin M.; Fitzpatrick, Thomas B. (2003). Fitzpatrick's dermatology in medicine. New York: McGraw-Hill, Medical Pub. Division.  
  7. ^ a b c d e f Alopecia Areata at Merck Manual of Diagnosis and Therapy Professional Edition
  8. ^ a b c American Osteopathic College of Dermatology. Alopecia Areata. Dermatologic Disease Database. Retrieved on December 3, 2007.
  9. ^ Wasserman, Dan; Guzman-Sanchez, Daniela Araucaria; Scott, Kimberly; McMichael, Amy (2007). "Alopecia areata". International Journal of Dermatology 46 (2): 121–31.  
  10. ^ Rudnicka, Lidia; Olszewska, Malgorzata; Rakowska, Adriana; Kowalska-Oledzka, Elzbieta; Slowinska, Monika (2008). "Trichoscopy: A new method for diagnosing hair loss". Journal of drugs in dermatology 7 (7): 651–4.  
  11. ^ Martinez-Mir, Amalia; Zlotogorski, Abraham; Gordon, Derek; Petukhova, Lynn; Mo, Jianhong; Gilliam, T. Conrad; Londono, Douglas; Haynes, Chad; Ott, Jurg; Hordinsky, Maria; Nanova, Krassimira; Norris, David; Price, Vera; Duvic, Madeleine; Christiano, Angela M. (2007). "Genomewide Scan for Linkage Reveals Evidence of Several Susceptibility Loci for Alopecia Areata". The American Journal of Human Genetics 80 (2): 316–28.  
  12. ^ Duncan, F Jason; Silva, Kathleen A; Johnson, Charles J; King, Benjamin L; Szatkiewicz, Jin P; Kamdar, Sonya P; Ong, David E; Napoli, Joseph L; Wang, Jinshan; King, Lloyd E; Whiting, David A; McElwee, Kevin J; Sundberg, John P; Everts, Helen B (2012). "Endogenous Retinoids in the Pathogenesis of Alopecia Areata". Journal of Investigative Dermatology 133 (2): 334–43.  
  13. ^ Petukhova, Lynn; Duvic, Madeleine; Hordinsky, Maria; Norris, David; Price, Vera; Shimomura, Yutaka; Kim, Hyunmi; Singh, Pallavi; Lee, Annette; Chen, Wei V.; Meyer, Katja C.; Paus, Ralf; Jahoda, Colin A. B.; Amos, Christopher I.; Gregersen, Peter K.; Christiano, Angela M. (2010). "Genome-wide association study in alopecia areata implicates both innate and adaptive immunity". Nature 466 (7302): 113–7.  
  14. ^ Safavi, Kayvon H.; Muller, Sigfrid A.; Suman, Vera J.; Moshell, Alan N.; Melton, L. Joseph (1995). "Incidence of Alopecia Areata in Olmsted County, Minnesota, 1975 Through 1989". Mayo Clinic Proceedings 70 (7): 628–33.  
  15. ^ Columbia university medical center newsletter

External links

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases at NIH
  • DermAtlas 42
  • National Alopecia Areata Foundation
  • Canadian Alopecia Areata Foundation
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.